Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK TRANSACTIONS (Details Narrative)

COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)			1 Months Ended					3 Months Ended		9 Months Ended
COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)	Aug. 09, 2021	Apr. 14, 2021	Jan. 31, 2022	Sep. 30, 2021	Aug. 31, 2021	Jan. 31, 2021	Sep. 30, 2020	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Class of Stock [Line Items]
Proceeds from Warrant Exercises										$ 880	$ 0
Third S 3 Shelf Offering [Member]
Class of Stock [Line Items]
Stock issued new, shares		19,100,000
Proceeds from sale of equity		$ 87,400,000
Warrants exercised, shares		2,500,000
First Offering [Member]
Class of Stock [Line Items]
Proceeds from sale of equity	$ 15,000,000
Proceeds from Warrant Exercises					$ 10,720,000
Common Stock [Member] \| First Offering [Member]
Class of Stock [Line Items]
Conversion of Stock, Shares Issued					2,522,387
Warrants [Member] \| First Offering [Member]
Class of Stock [Line Items]
Conversion of Stock, Shares Converted					2,522,387
Proceeds from Warrant Exercises					$ 10,720,000
Non Employee Board Member 1 [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock issued for compensation, shares												1,334
Non Employee Board Member 2 [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock issued for compensation, shares												1,334
Non Employee Board Member 3 [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock issued for compensation, shares												1,334
Three Nonemployee Board Members [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 0	$ 0	4,342
Number of nonvested shares								0		0
A Consultant [Member] \| Medical And Scientific Advisory Board [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 0	$ 0	$ 3,542
Number of nonvested shares			0					0	0	0	0
Number of shares issued for compensation							333
Officers [Member] \| Compensation Agrmt 2021 [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 7,370	$ 0	$ 29,480
Number of nonvested shares			0					0	0	0	0
Number of shares issued for compensation						4,400
Officers [Member] \| Compensation Agrmt 2022 [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 666	$ 916	$ 7,333	$ 916
Number of nonvested shares			0					0	0	0	0
Number of shares issued for compensation			4,400
Three Nonemployee Members 1 [Member] \| Director Letter Agreement [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 6,056	$ 0	$ 16,792
Number of nonvested shares			0					0	0	0	0
Number of shares issued for compensation											1,336
Two Consultants [Member] \| Consulting Agreements [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 2,442	$ 0	$ 6,504
Number of nonvested shares			84					0	84	0	84
Number of shares issued for compensation											334
A Consultant 1 [Member] \| Medical And Scientific Advisory Board [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 265	$ 0	$ 353
Number of nonvested shares			0					0	0	0	0
Number of shares issued for compensation				334
Three Nonemployee 2 Members [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Number of nonvested shares			0					0	0	0	0
Three Nonemployee 2 Members [Member] \| Director Letter Agreement [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 0	$ 0	$ 2,278	$ 0
Number of shares issued for compensation										1,002